Literature DB >> 2515443

Investigation by NMR spectroscopy of the interaction between synthetic soluble (-)-dopa melanin and drugs.

M M Salazar-Bookaman1, J Fowble, P Weber, P N Patil.   

Abstract

In order to understand the molecular interactions of drugs with melanin, synthetic soluble (-)-dopa-melanin was prepared in deuterium buffer. The spectra of various drug moieties with the pigment at 30 degrees C were studied employing the line width measurements obtained with a pulse NMR (AF270) instrument. As compared to drug effects in fresh melanins (48 h), the aged melanins (greater than or equal to 168 h) gave consistent spectral measurements, even in dilute solutions of pigment. NMR signals of aromatic and N-methyl protons of drugs were relatively easy to quantify and, in the presence of melanin, line broadening of various drug moieties occurred. The line widths of the N-methyl groups of acetylcholine (3.02 ppm), the N-methyl group of atropine (2.52 ppm), N-isopropyl of isoprenaline bitartrate (1.14 ppm) and N-ter-butyl of timolol maleate (1.22 ppm) in the presence of the pigment were increased. Line widths associated with acetate, bitartrate, maleate or tropic acid, however, were not altered by the melanin. This indicates the specificity of the interaction between drug moieties and the site(s) of melanin. Based on the line width measurements of N-methyl protons of ephedrine, two dissociation constants were obtained (Kd1 2.08 mM and Kd2 greater than 20 mM). The constants for atropine melanin complex were Kd1 0.79 mM and Kd2 greater than 6 mM. Furthermore, based on N-methyl resonances, it appears that atropine and ephedrine compete for at least one common interacting site of the melanin polymer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515443     DOI: 10.1007/bf00260613

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Chemical structure of melanins.

Authors:  G A SWAN
Journal:  Ann N Y Acad Sci       Date:  1963-02-15       Impact factor: 5.691

2.  The application of nuclear magnetic resonance to pharmacological problems.

Authors:  A S Burgen; J C Metcalfe
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

3.  Accumulation of (-)-14C-ephedrine by the pigmented and the nonpigmented iris.

Authors:  P N Patil; K Shimada; D R Feller; L Malspeis
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

4.  Studies related to the chemistry of melanins. 8. The pyrrolecarboxylic acids formed by oxidation or hydrolysis of melanins derived from 3,4-dihydroxyphenethylamine or (plus or minus)-3,4-dihydroxyphenylalanine.

Authors:  F Binns; R F Chapman; N C Robson; G A Swan; A Waggott
Journal:  J Chem Soc Perkin 1       Date:  1970

5.  Affinity of ocular acid-insoluble melanin for drugs in vitro.

Authors:  M Tsuchiya; S Hayasaka; K Mizuno
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-05       Impact factor: 4.799

6.  The extraneuronal uptake and metabolism of 3H-isoprenaline in the rabbit iris.

Authors:  P N Patil; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

7.  Measurement of ligand binding with nuclear magnetic resonance spectroscopy.

Authors:  C E Brown
Journal:  J Neurosci Methods       Date:  1981-04       Impact factor: 2.390

8.  Iris pigmentation and atropine mydriasis.

Authors:  M Salazar; K Shimada; P N Patil
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

9.  Binding characteristics of drugs to synthetic levodopa melanin.

Authors:  K Shimada; R Baweja; T Sokoloski; P N Patil
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

10.  Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.

Authors:  K B Stepień; T Wilczok
Journal:  Biochem Pharmacol       Date:  1982-11-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.